Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

More work at P&G on metalloprotease inhibitors

June 4, 1998

Genetics Institute claims series with PLA2-inhibitory activity

June 4, 1998

Procter & Gamble prepares inhibitors of mammalian metalloproteases

June 3, 1998

MMP/TNF-alpha convertase inhibitors disclosed by Agouron

June 1, 1998

Preparation and use of MMP/TNF production inhibitors described by Pfizer

May 29, 1998

RCT describes truncated chemokine analogues for rheumatoid arthritis

May 28, 1998

JTE-522 suppresses recurrent allergic inflammation in rats

May 28, 1998

Oxis presents new antiinflammatory agents with multiple mechanisms of action

May 27, 1998

Imidazole cytokine inhibitors prepared at SKB

May 27, 1998

Modified oligosaccharide cell adhesion inhibitors developed at Novartis

May 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...